What antidepressant is appropriate for a 73-year-old patient?

Antidepressant Selection for a 73-Year-Old Patient

For a 73-year-old patient with depression, start with sertraline or citalopram at half the standard adult dose (sertraline 25-50 mg daily or citalopram 10 mg daily), as these SSRIs have the most favorable safety profiles in older adults. 1

Preferred First-Line Agents

The following SSRIs are recommended as first-line options based on their favorable adverse effect profiles in geriatric populations 1:

• Sertraline (25-50 mg daily): Well-tolerated with less effect on metabolism of other medications compared to other SSRIs 2
• Citalopram (10 mg daily, maximum 40 mg): Highest ratings for efficacy and tolerability among experts; well-tolerated though some patients experience nausea and sleep disturbances 2, 1
• Escitalopram (10 mg daily): Favorable adverse effect profile 1

Alternative Options

If SSRIs are not tolerated or contraindicated:

• Mirtazapine (7.5 mg at bedtime, maximum 30 mg): Potent and well-tolerated; promotes sleep, appetite, and weight gain—useful if insomnia or poor appetite are prominent 2
• Venlafaxine (37.5 mg daily): Acceptable alternative with favorable profile 1
• Bupropion: Appropriate choice with favorable profile 1

Critical Agents to AVOID in Older Adults

Do not use paroxetine or fluoxetine in patients 73 years old 1:

• Paroxetine: Associated with more anticholinergic effects 1
• Fluoxetine: Greater risk of agitation and overstimulation; very long half-life means side effects may not manifest for weeks 2, 1
• Tertiary-amine TCAs (amitriptyline, imipramine): Significant adverse anticholinergic effects; considered potentially inappropriate per Beers Criteria 1, 3

Dosing Principles for Geriatric Patients

• Start at approximately 50% of the standard adult starting dose due to slower metabolism and increased sensitivity to side effects 1
• Increase dosage using increments of the initial dose every 5-7 days until therapeutic benefits or significant side effects appear 2
• A full therapeutic trial requires at least 4-8 weeks 2

Real-World Evidence Considerations

Recent real-world data from Denmark involving 93,883 older adults (mean age 78 years) showed that compared to sertraline users 4:

• Mirtazapine users had significantly higher risks of discontinuation (IRR=1.55), cardiovascular events, and mortality 4
• Venlafaxine users had higher risks of discontinuation (IRR=1.22) and switching (IRR=1.47) 4
• Sertraline demonstrated the most favorable overall outcome profile in this elderly population 4

This real-world evidence supports sertraline as the reference standard, though it contrasts somewhat with the guideline preference for citalopram, which received highest expert ratings for tolerability 2, 1.

Treatment Duration

• Continue treatment for 4-12 months after first episode of major depressive disorder 1
• After 2 episodes: Consider 1-3 years of treatment 5
• After 3+ episodes: Consider treatment longer than 3 years given 90% recurrence probability 1

Adjunctive Treatment

Combine antidepressant medication with psychotherapy (cognitive-behavioral therapy, supportive psychotherapy, problem-solving therapy, or interpersonal psychotherapy) for optimal outcomes 2, 6, 5.

Common Pitfalls to Avoid

• Do not use fixed low doses without titration—older adults still require adequate dosing for efficacy, just with slower titration 2
• Monitor for hyponatremia with SSRIs, particularly in the very elderly 1
• Assess for upper GI bleeding risk, especially if patient takes NSAIDs concurrently (adjusted OR 15.6 with combined use) 7
• Screen for drug-drug interactions given polypharmacy is common in this age group 2, 5
• Reassess need for medication after 9 months by attempting dosage reduction 2